METTL14 and atherosclerosis: METTL14 is documented to methylate pri-miR-19a and promote the processing of the mature miR-19a, stimulating the proliferation and invasion of atherosclerotic vascular endothelial cells, indicating that the METTL14/m6A/miR-19a axis may represent a novel target for anti-atherosclerosis treatment (20).